, Tracking Stock Market Picks
Enter Symbol:
C.r. Bard, Inc. (BCR) [hlAlert]

down 48.58 %

C.r. Bard, Inc. (BCR) rated Underweight by Morgan Stanley

Posted on: Thursday,  Jan 3, 2013  8:25 AM ET by Morgan Stanley

Morgan Stanley rated Underweight C.r. Bard, Inc. (NYSE: BCR) on 01/03/2013, when the stock price was $101.02. Since
then, C.r. Bard, Inc. has gained 94.51% as of 01/20/2016's recent price of $196.49.
If you would have followed this Morgan Stanley's recommendation on BCR, you would have lost 48.58% of your investment in 1112 days.

C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas.

Morgan Stanley Investment Research is one of the financial industry's dominant thought leaders in equity and fixed-income investing. Our analysts, economists, and strategists have earned this reputation through timely, in-depth analysis of companies, industries, markets, and the world’s economies. Our teams collaborate to assist Morgan Stanley clients with investment decisions, using cash and derivative instruments across major asset classes and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/3/2013 8:25 AM Sell
as of 12/13/2013
1 Week up  2.79 %
1 Month up  3.18 %
3 Months down  -12.62 %
1 YTD down  -32.25 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy